Tag: Andrew Gwynne

The below Parliamentary question was asked by Andrew Gwynne on 2016-03-08.

To ask the Secretary of State for Health, whether his Department plans to run a second Be Clear on Cancer campaign on oesophago-gastric cancers.

Jane Ellison

There will be two national ‘Be Clear on Cancer’ campaigns in 2016-17. The decision on which cancers these campaigns will focus on will be informed by a steering group, whose members include primary and secondary care clinicians, analysts and key voluntary sector organisations. A number of factors are taken into account when deciding which campaigns to run, including all available evaluation data. A second national oesophago-gastric campaign will be considered alongside the other existing campaigns.

PHE is analysing cancer waiting times data and campaign tracking research and it is expected that the first national oesophago-gastric cancer (1st wave) interim report will be published this summer.

The below Parliamentary question was asked by Andrew Gwynne on 2016-03-21.

To ask the Secretary of State for Foreign and Commonwealth Affairs, how many badges of honour have been awarded by (a) Gibraltar, (b) the Falkland Islands, (c) the Cayman Islands and (d) Bermuda in each year since 2010.

James Duddridge

Since 2010 badges of honour have been awarded as follows;

Gibraltar: 2010 – 5; 2011 – 6; 2012 – 6; 2013 – 6; 2014 – 6; 2015 – 6

Falkland Islands: 2010 – 3; 2011 – 2; 2012 – 1; 2013 – 0; 2014 – 0; 2015 – 2

Cayman Islands: 2010 – 4; 2011 – 8; 2012 – 2; 2013 – 6; 2014 – 2; 2015 – 1

Bermuda: 2010 – 14; 2011 – 7; 2012 – 13; 2013 – 5; 2014 – 6; 2015 – 2

The below Parliamentary question was asked by Andrew Gwynne on 2016-04-13.

To ask the Secretary of State for Health, how many NHS organisations have been charged statutory interest as a result of late payment in the last three years.

George Freeman

Figures on the number of National Health Service bodies recording instances of expenditure incurred under the ‘Late payment of commercial debt (Interest) Act 1998’, where it was incurred with non-NHS bodies, in the last three years, are provided in the following table.

Sector	2012-13	2013-14	2014-15
NHS Trust	19	21	18
NHS Foundation Trust	9	14	15
Clinical Commissioning Groups1	0	N/A	N/A
Primary Care Trusts2	5	0	0
Strategic Health Authorities2	0	0	0
Total	33	35	33

1. Did not exist in 2012/13
2. Did not exist after 2012/13

Figures on the number of NHS bodies meeting the 30 day payment target for subcontractors, where the information is available from the central accounts returns made to the Department are shown in the following table.

Sector	NHS Trusts
Entities meeting Target	25
Total Entities in sector	99

The below Parliamentary question was asked by Andrew Gwynne on 2016-05-18.

To ask the Secretary of State for Education, if she will order an investigation to be undertaken into (a) financial management and (b) governance relating to the use of pupil premium funding at Audenshaw School Academy Trust.

Mr Sam Gyimah

The conditions of grant for the pupil premium make clear that its purpose is to raise the attainment of disadvantaged pupils. School leaders are best placed to decide how to spend the pupil premium in line with this policy and the needs of their pupils. Schools are not prevented from using the pupil premium to fund capital projects or from carrying over funding between years.

The Department for Education supports schools to make evidence-based decisions through the work of the Education Endowment Foundation, established to identify and promote effective practice in raising the attainment of disadvantaged pupils. The Department does not monitor how Academies and maintained schools spend the pupil premium but instead holds them to account for the outcomes of eligible pupils through the publication of data in performance tables and Ofsted inspection.

Where concerns are raised about the performance of an academy then they are addressed by the Regional School Commissioner with responsibility for that area. The Department also takes seriously any concerns about the financial management of a school. We are aware of the findings of the Ofsted report on Audenshaw School relating to its use of the pupil premium, following an inspection in February 2016. We are also aware that the Hon. Member, Andrew Gwynne, has met the Regional Schools Commissioner for Lancashire and West Yorkshire, Vicky Beer, on a number of occasions to discuss his concerns about Audenshaw School Academy Trust. The Department has carefully reviewed all the information provided on this matter and has identified no grounds to take further action.

The below Parliamentary question was asked by Andrew Gwynne on 2016-05-18.

To ask the Secretary of State for Health, what the rate of smoking is in England among people over the age of 18.

Jane Ellison

In 2015, figures showed smoking prevalence rates in adults and 15 year olds in England to be at 18% and 8% respectively. The most recent quarterly information on prevalence of smoking among pregnant women, published in March, show this to be 10.6%.

Smoking prevalence is at its lowest ever level with official figures showing that the Government met each of the targets set out in its Tobacco Control Plan – Healthy Lives, Healthy People. A new Tobacco Control Plan is currently being developed.

The below Parliamentary question was asked by Andrew Gwynne on 2016-05-24.

To ask the Secretary of State for Health, what additional funding his Department plans to make available for implementation of the recommendations of the Independent Cancer Taskforce.

Jane Ellison

By 2020-21, the Government will increase funding for the National Health Service by £10 billion a year in real terms compared with 2014-15, to support the implementation of the NHS’s own plan – the NHS Five Year Forward View – to transform services across the country. The Government is backing the NHS plan and enabling it to go further – by investing £2 billion more than the £8 billion the NHS asked for – delivering government objectives including improved access to cancer treatments.

As part of the response to the independent Cancer Taskforce’s recommendations, in September 2015, we announced funding of up to £300 million a year by 2020 to increase diagnostic capacity to meet the new target that patients will be given a definitive cancer diagnosis, or the all clear, within 28 days of being referred by a general practitioner.

The below Parliamentary question was asked by Andrew Gwynne on 2016-06-08.

To ask the Secretary of State for Health, what assessment NHS England has made of variation in aseptic services and the delivery of high quality infusional chemotherapy to cancer patients.

Jane Ellison

NHS England Specialist Pharmacy Services have to date not undertaken a comprehensive assessment of aseptic capacity to meet the future demands for chemotherapy provision in England. They are currently working closely with colleagues at the Department and NHS Improvement to support a number of regionally based reviews of aseptic capacity and to help trusts develop local and regional Hospital Pharmacy Transformation plans, as recommended by Lord Carter in February 2016.

The Medicines and Healthcare products Regulatory Agency (MHRA) is an executive agency of the Department and is responsible for regulating unlicensed medicines under a Manufacturer’s ‘Specials’ Licence. The General Pharmaceutical Council (GPhC) and Care Quality Commission (CQC) are responsible for regulating medicine prepared extemporaneously in a register pharmacy or hospital pharmacy respectively under the professional exemption.

MHRA will collaborate with the NHS, GPhC and CQC though inspections of MHRA licensed aseptic facilities or joint investigations of aseptic facilities in hospitals where there are patient safety concerns.

The below Parliamentary question was asked by Andrew Gwynne on 2016-07-19.

To ask the Secretary of State for Health, what steps the NHS plans to take to maintain the availability of selective dorsal rhizotomy for children with cerebral palsy during the Commissioning through Evaluation analysis phase.

David Mowat

Recruitment of patients for the commissioning through evaluation process for the Selective Dorsal Rhizotomy procedure has now concluded, and an evaluation of the long term benefits is now in the analysis phase. There are no plans to provide Selective Dorsal Rhizotomy surgery to additional patients during this time.

The below Parliamentary question was asked by Andrew Gwynne on 2016-09-14.

To ask the Secretary of State for Health, whether his Department has had discussions with NICE on the Afinitor form of everolimus.

Nicola Blackwood

Departmental officials are in regular contact with their counterparts at the National Institute for Health and Care Excellence (NICE) about a range of issues, including individual medicines. This includes discussions on everolimus through the established topic selection processes for NICE’s technology appraisal programme and in relation to potential patient access schemes proposed by the manufacturer.

NICE has appraised everolimus for a number of indications and is currently appraising it for others.

The below Parliamentary question was asked by Andrew Gwynne on 2016-10-11.

To ask the Secretary of State for Health, how many instances were recorded in which a person was restrained physically by placing their face on the floor in a mental health ward in each year from 2012.

Nicola Blackwood

Prone restraint data for years since 2012 is not available. NHS Digital began collecting the number of incidents of prone restraint on mental health wards for adults and for children and young people in January 2016. In line with the UK Statistics Authority’s Code of Practice, this data is undergoing evaluation.